RHHBY
Roche Holding AG
OTC Markets OTCQXUSDEQUITY
DELAYED
Last price
58.10
▲ 0.85 (1.48%)
MARKET · —
Price
Open
57.25
Prev close
57.25
Day high
58.58
Day low
57.33
Volume
272.88K
Market cap
—
P/E (TTM)
—
52W range
39.50 – 60.85
Trailing performance
Returnvs SPY
1W
+6.57%
+7.9%
1M
+7.75%
+4.0%
3M
+10.23%
+7.1%
6M
-2.11%
-13.2%
YTD
+12.66%
+0.4%
1Y
+42.58%
+22.6%
3Y
+57.79%
-16.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
56.43
+2.97% from price
SMA 20
56.04
+3.68% from price
SMA 50
53.30
+9.00% from price
SMA 100
52.13
+11.45% from price
SMA 200
52.10
+11.52% from price
EMA 12
56.40
+3.02% from price
EMA 26
55.31
+5.05% from price
EMA 50
54.09
+7.41% from price
RSI (14)
63.2
Neutral
MACD (12,26,9)
1.09
Hist 0.05
ATR (14)
1.19
2.04% of price
Realised vol 30D
28.4%
Annualised
Bollinger upper
58.33
20, 2σ
Bollinger lower
53.75
20, 2σ
50 / 200 cross
Golden
53.30 vs 52.10
Trend bias
Above 200
+11.52%
Risk profile
Beta vs SPY
0.33
Less volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
28.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-21.8%
Peak to trough
Max drawdown 5Y
-45.2%
Peak to trough
ATR 14
1.19
2.04% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Is Roche Holding (SWX:ROP) Fully Valued After Its Latest US Manufacturing Push?
Simply Wall St. · 16h ago
Roche commits $750m to double Oregon-based US manufacturing capacity
Pharmaceutical Technology · 1d ago
Roche (SWX:ROP) Stock Could Be Below Fair Value After US Manufacturing Expansion
Simply Wall St. · 1d ago
Roche’s US subsidiary Genentech announces manufacturing expansion in the United States
GlobeNewswire · 2d ago
Analog Devices Q3 Earnings Call Highlights AI Power Growth Runway
Zacks · 2d ago
Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
Business Wire · 2d ago
Why Is Merck Stock Still Undervalued After An 80% Surge?
Trefis · 2d ago
Real Parkinson’s Disease Hope from Jupiter Neurosciences
Exec Edge · 3d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.